» Articles » PMID: 9437276

Epileptic Seizures After a First Stroke: the Oxfordshire Community Stroke Project

Overview
Journal BMJ
Specialty General Medicine
Date 1998 Jan 23
PMID 9437276
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe the immediate and long term risk of epileptic seizures after a first ever stroke.

Design: Cohort study following up stroke survivors for 2 to 6.5 years; comparison with age specific incidence rates of epileptic seizures in the general population.

Setting: Community based stroke register.

Subjects: 675 patients with a first stroke, followed up for a minimum of 2 years.

Main Outcome Measures: Occurrence of single and recurrent seizures.

Results: 52 patients had one or more post stroke seizures; in 25 the seizures were recurrent. The 5 year actuarial risk of a post stroke seizure in survivors (excluding 19 patients with a history of epilepsy and 3 patients in whom the seizure occurred shortly before death from another cause) was 11.5% (95% confidence interval 4.8% to 18.2%). The relative risk of seizures, in comparison with the general population, was estimated at 35.2 in the first year after stroke and 19.0 in year 2. The risk of seizures was increased in survivors of subarachnoid and intracerebral haemorrhage (hazard ratio for intracranial haemorrhage v cerebral infarction 10.2 (3.7 to 27.9)). The risk of seizures after ischaemic stroke was substantial only in patients presenting with severe strokes due to total anterior circulation infarction. Only 9 of 295 patients (3%) independent one month after stroke suffered a seizure between 1 month and 5 years (actuarial risk 4.2% (0.1% to 8.3%)).

Conclusion: Stroke patients have about an 11.5% risk of single or recurrent seizures in the first 5 years after a stroke. Patients with more severe strokes or haemorrhagic strokes are at higher risk.

Citing Articles

Cardiovascular risk factor assessment in late-onset seizures: A study protocol to assess the value of structured intervention.

Larsson D, Asberg S, Sundstrom J, Frid P, Zelano J Epilepsia Open. 2024; 9(4):1611-1617.

PMID: 38874366 PMC: 11296115. DOI: 10.1002/epi4.12987.


Efficacy and safety of Perampanel in the treatment of post stroke epilepsy: A multicenter, real-world study.

Yan C, Yang T, Sun Y, Hu J, Yi X, Li C Heliyon. 2024; 10(5):e26376.

PMID: 38434369 PMC: 10907510. DOI: 10.1016/j.heliyon.2024.e26376.


Risk Factors Associated with Epilepsy Related to Cerebrovascular Disease: A Systematic Review and Meta-Analysis.

Mafla-Mendoza A, Paredes-Urbano E, Gea-Izquierdo E Neuropsychiatr Dis Treat. 2024; 19:2841-2856.

PMID: 38161512 PMC: 10757781. DOI: 10.2147/NDT.S439995.


Post-stroke seizures, epilepsy, and mortality in a prospective hospital-based study.

Freiman S, Hauser W, Rider F, Yaroslavskaya S, Sazina O, Vladimirova E Front Neurol. 2023; 14:1273270.

PMID: 38107633 PMC: 10722584. DOI: 10.3389/fneur.2023.1273270.


Role of the glymphatic system and perivascular spaces as a potential biomarker for post-stroke epilepsy.

Hlauschek G, Nicolo J, Sinclair B, Law M, Yasuda C, Cendes F Epilepsia Open. 2023; 9(1):60-76.

PMID: 38041607 PMC: 10839409. DOI: 10.1002/epi4.12877.